KRAS G12A

Clinical trials for KRAS G12A explained in plain language.

Never miss a new study

Get alerted when new KRAS G12A trials appear

Sign up with your email to follow new studies for KRAS G12A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New shot aims to stop aggressive cancers from coming back

Disease control Ongoing

This trial is testing a new immunotherapy called ELI-002 7P. It is for people with pancreatic or colorectal cancer that has a specific genetic change (KRAS or NRAS mutation) and who have already had surgery and chemotherapy. The goal is to see if this treatment can safely help th…

Matched conditions: KRAS G12A

Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

KRAS G12A

Get alerted when new KRAS G12A trials appear

New shot aims to stop aggressive cancers from coming back